5979-11-3

• 常用中文名：舒缓激肽三醋酸盐
• 常用英文名：Bradykinin triacetate salt
• CAS号：5979-11-3
• 分子式：C₅₆H₈₅N₁₅O₁₇
• 分子量：1240.36000
• 发布时间：2018-04-16 08:00:00
• 更新时间：2024-01-02 08:57:02
• 下载msds

名称

• 中文名: 舒缓激肽三醋酸盐
• 英文名: n-formyl-met-leu-phe
• 中文别名: 缓激肽
• 英文别名: bradykinin acetate; FORMYL-MET-LEU-PHE-OH; FORMYL-MLF; MFCD00036780; EINECS 227-781-2; RR-9; N-FORMYL-L-MET-LEU-PHE; CHEMOTACTIC PEPTIDE; FOR-MET-LEU-PHE; FOR-MET-LEU-PHE-OH; FMLP

物化性质

• 沸点: 1618.8ºC at 760 mmHg
• 熔点: 150-160ºC
• 分子式: C₅₆H₈₅N₁₅O₁₇
• 分子量: 1240.36000
• 闪点: 932.8ºC
• 精确质量: 1239.62000
• PSA: 525.68000
• LogP: 1.55400
• 外观性状: 白色粉末
• 储存条件:

  2-8℃避光，阴凉干燥处，密封保存

• 稳定性:

  常温常压下稳定

• 水溶解性: DMF: 50 mg/mL, clear, colorless
• 分子结构:

  1、 摩尔折射率：116.45

  2、 摩尔体积（m³/mol）：364.9

  3、 等张比容（90.2K）：965.9

  4、 表面张力（dyne/cm）：49.0

  5、 极化率（10 ^-24cm ³）：46.16

• 计算化学:

  1、 疏水参数计算参考值（XlogP）：

  2、 氢键供体数量：15

  3、 氢键受体数量：24

  4、 可旋转化学键数量：27

  5、 互变异构体数量：128

  6、 拓扑分子极性表面积（TPSA）：531

  7、 重原子数量：88

  8、 表面电荷：0

  9、 复杂度：2110

  10、 同位素原子数量：0

  11、 确定原子立构中心数量：0

  12、 不确定原子立构中心数量：8

  13、 确定化学键立构中心数量：0

  14、 不确定化学键立构中心数量：0

  15、 共价键单元数量：4

• 更多:

  1. 性状：白色粉末

  2. 密度（g/mL,25/4℃）：未确定

  3. 相对蒸汽密度（g/mL,空气=1）：未确定

  4. 熔点（ºC）：未确定

  5. 沸点（ºC,常压）：未确定

  6. 沸点（ºC,5.2kPa）：未确定

  7. 折射率：未确定

  8. 闪点（ºC）：未确定

  9. 比旋光度（º）：未确定

  10. 自燃点或引燃温度（ºC）：未确定

  11. 蒸气压（kPa,25ºC）：未确定

  12. 饱和蒸气压（kPa,60ºC）：未确定

  13. 燃烧热（KJ/mol）：未确定

  14. 临界温度（ºC）：未确定

  15. 临界压力（KPa）：未确定

  16. 油水（辛醇/水）分配系数的对数值：未确定

  17. 爆炸上限（%,V/V）：未确定

  18. 爆炸下限（%,V/V）：未确定

  19. 溶解性：溶于DMSO，50mg/mL

MSDS

Name: Bradykinin Diacetate Heptahydrate 98% (HPLC) Material Safety Data Sheet Synonym: None known CAS: 5979-11-3 Section 1 - Chemical Product MSDS Name:Bradykinin Diacetate Heptahydrate 98% (HPLC) Material Safety Data Sheet Synonym:None known Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS CAS# Chemical Name content EINECS# 5979-11-3 Bradykinin Diacetate Heptahydrate 98 227-781-2 Hazard Symbols: None Listed. Risk Phrases: None Listed. Section 3 - HAZARDS IDENTIFICATION EMERGENCY OVERVIEW The toxicological properties of this material have not been fully investigated. Potential Health Effects Eye: May cause eye irritation. Skin: May cause skin irritation. Ingestion: May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated. Inhalation: May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated. Chronic: No information found. Section 4 - FIRST AID MEASURES Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid. Skin: Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse. Ingestion: Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water. Inhalation: Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid. Notes to Physician: Section 5 - FIRE FIGHTING MEASURES General Information: As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Extinguishing Media: Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam. Section 6 - ACCIDENTAL RELEASE MEASURES General Information: Use proper personal protective equipment as indicated in Section 8. Spills/Leaks: Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions. Provide ventilation. Section 7 - HANDLING and STORAGE Handling: Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation. Storage: Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Deep freeze (below -20C). Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION Engineering Controls: Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low. Exposure Limits CAS# 5979-11-3: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166. Skin: Wear appropriate protective gloves to prevent skin exposure. Clothing: Wear appropriate protective clothing to prevent skin exposure. Respirators: A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use. Section 9 - PHYSICAL AND CHEMICAL PROPERTIES Physical State: Solid Color: white Odor: none reported pH: Not available. Vapor Pressure: Not available. Viscosity: Not available. Boiling Point: Not available. Freezing/Melting Point: Not available. Autoignition Temperature: Not applicable. Flash Point: Not applicable. Explosion Limits, lower: Not available. Explosion Limits, upper: Not available. Decomposition Temperature: Solubility in water: Specific Gravity/Density: Molecular Formula: C54H81N15O13.7H2O Molecular Weight: 1306.45 Section 10 - STABILITY AND REACTIVITY Chemical Stability: Stable under normal temperatures and pressures. Conditions to Avoid: Incompatible materials, dust generation, excess heat, strong oxidants. Incompatibilities with Other Materials: Oxidizing agents. Hazardous Decomposition Products: Nitrogen oxides, carbon monoxide, irritating and toxic fumes and gases, carbon dioxide. Hazardous Polymerization: Has not been reported Section 11 - TOXICOLOGICAL INFORMATION RTECS#: CAS# 5979-11-3 unlisted. LD50/LC50: Not available. Carcinogenicity: Bradykinin Diacetate Heptahydrate - Not listed by ACGIH, IARC, or NTP. Section 12 - ECOLOGICAL INFORMATION Section 13 - DISPOSAL CONSIDERATIONS Dispose of in a manner consistent with federal, state, and local regulations. Section 14 - TRANSPORT INFORMATION IATA Not regulated as a hazardous material. IMO Not regulated as a hazardous material. RID/ADR Not regulated as a hazardous material. Section 15 - REGULATORY INFORMATION European/International Regulations European Labeling in Accordance with EC Directives Hazard Symbols: Not available. Risk Phrases: Safety Phrases: S 24/25 Avoid contact with skin and eyes. S 28A After contact with skin, wash immediately with plenty of water. S 37 Wear suitable gloves. S 45 In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible). WGK (Water Danger/Protection) CAS# 5979-11-3: No information available. Canada None of the chemicals in this product are listed on the DSL/NDSL list. CAS# 5979-11-3 is not listed on Canada's Ingredient Disclosure List. US FEDERAL TSCA CAS# 5979-11-3 is not on the TSCA Inventory because it is a hydrate. It is considered to be listed if the CAS number for the anhydrous form is on the inventory (40CFR720.3(u)(2)). SECTION 16 - ADDITIONAL INFORMATION N/A

毒性和生态

生态学数据: 通常对水是不危害的，若无政府许可，勿将材料排入周围环境.

安全

• 危害码 (欧洲): Xi
• 安全声明 (欧洲): S22-S24/25
• WGK德国: 3